Sorted By:

Relevance


Counterfeit Drug Penalty Enhancement Act of 2011 Can Help Crack Down on Counterfeiting Crimes

PhRMA  |  Press Release

(November 17, 2011) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani released the following statement regarding the bipartisan and bicameral Counterfeit Drug Penalty Enhancement Act of 2011: “Senators Leahy and Grassley as well as Representatives Meehan and Linda Sanchez should be applauded for taking steps to protect patients by advocating for stricter sentences for criminals in the counterfeit medicine business.
https://www.phrma.org/press-release/counterfeit-drug-penalty-enhancement-act-of-2011-can-help-crack-down-on-counterfeiting-crimes

PhRMA Applauds Tenure of FDA Commissioner Hamburg

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-applauds-tenure-of-fda-commissioner-hamburg

Partnership for Prescription Assistance Celebrates 10th Anniversary of Assisting Uninsured and Underinsured Patients

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA  
https://www.phrma.org/press-release/partnership-for-prescription-assistance-celebrates-10th-anniversary-of-assisting-uninsured-and-underinsured-patients

PhRMA Statement on ASCO Value Framework

PhRMA  |  Press Release

Washington, D.C. (June 22, 2015) — Pharmaceutical Research and Manufacturers of America (PhRMA) executive vice president, policy and research, Lori Reilly provided the following statement on the American Society of Clinical Oncology's (ASCO) conceptual framework for assessing the...
https://www.phrma.org/press-release/phrma-statement-on-asco-value-framework

PhRMA Statement Regarding White House Jobs Summit

PhRMA  |  Press Release

 Washington, D.C. (December 3, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) [learn more] President and CEO Billy Tauzin issued the following statement today regarding President Obama’s .whitehouse...
https://www.phrma.org/press-release/phrma-statement-regarding-white-house-jobs-summit

PhRMA Applauds Expeditious Selection of FDA Leadership

PhRMA  |  Press Release

Washington, D.C. (March 14, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding President Obama’s selection of a new Food and Drug Administration leader: “PhRMA applauds Presiden...
https://www.phrma.org/press-release/phrma-applauds-expeditious-selection-of-fda-leadership

Prescriber Data Critical to Ensure Patient Safety

PhRMA  |  Press Release

Washington, D.C. (June 23, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President Josephine Martin issued the following statement regarding the Supreme Court’s opinion on prescriber data: “Today’s opinion by the U.S. Supreme Court is ...
https://www.phrma.org/press-release/prescriber-data-critical-to-ensure-patient-safety

Nearly 100 New Medicines in Development for Arthritis

PhRMA  |  Press Release

Washington, D.C. (July 24, 2014) — America’s biopharmaceutical research companies are developing 92 innovative new medicines to help the millions of Americans affected by arthritis, according to a new .phrma.org/sites/default/files/pdf/2014-meds-in-dev-arthriti...
https://www.phrma.org/press-release/nearly-100-new-medicines-in-development-for-arthritis

PhRMA Statement on Industry Support of Medical Education

PhRMA  |  Press Release

Washington, D.C. (July 29, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement regarding industry support of continuing professional medical education: “Because medicine constantly changes – ...
https://www.phrma.org/press-release/phrma-statement-on-industry-support-of-medical-education

Christopher Viehbacher Becomes New PhRMA Board Chairman

PhRMA  |  Press Release

Washington, D.C. (December 6, 2010) – Christopher Viehbacher, chief executive officer of sanofi-aventis, became chairman of the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) today upon the resignation of Jeffrey B. Kindler of Pfizer. ...
https://www.phrma.org/press-release/christopher-viehbacher-becomes-new-phrma-board-chairman

PhRMA Endorses FDA Safety Over Sequestration Act

PhRMA  |  Press Release

WASHINGTON, D.C. (July 22, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President of Scientific and Regulatory Affairs Sascha Haverfield, PhD, issued the following statement today on ongoing efforts in Congress to resolve the sequestration of prescrip...
https://www.phrma.org/press-release/phrma-endorses-fda-safety-over-sequestration-act

PhRMA Statement on the Health Care Reform Agreement

PhRMA  |  Press Release

Washington, D.C. (June 21, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement regarding the agreement with the W...
https://www.phrma.org/press-release/phrma-statement-on-the-health-care-reform-agreement

Researchers and Patient Advocates Honored with PhRMA Award

PhRMA  |  Press Release

Washington, D.C. (September 7, 2012)— The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the recipients of the first annual Research and Hope Awards. This year’s award honors outstanding achievements in academia, the biopharmaceutical research sector...
https://www.phrma.org/press-release/researchers-and-patient-advocates-honored-with-phrma-award

PhRMA Statement on Foreign Clinical Trials

PhRMA  |  Press Release

Washington, D.C. (June 22, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding clinical trials conducted abroad: “America’s biopharmaceutical research ...
https://www.phrma.org/press-release/phrma-statement-on-foreign-clinical-trials

PhRMA Statement Regarding User Fee Act Reauthorization

PhRMA  |  Press Release

Washington, D.C. (September 1, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President for Scientific and Regulatory Affairs Dr. David E. Wheadon issued the following statement...
https://www.phrma.org/press-release/phrma-statement-regarding-user-fee-act-reauthorization

PhRMA Statement Regarding Benefits of U.S. Innovation

PhRMA  |  Press Release

Washington, D.C. (August 25, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today in response to ‘Global Drug Discovery: Europe Is Ahead,’ a paper published ...
https://www.phrma.org/press-release/phrma-statement-regarding-benefits-of-u-s-innovation

PhRMA Statement on Economic Stimulus Law

PhRMA  |  Press Release

Washington, D.C. (February 17, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding the economic stimulus package getting signed into law by President Obama: "The economic stimulu...
https://www.phrma.org/press-release/phrma-statement-on-economic-stimulus-law

PhRMA Statement on PDUFA Reauthorization - 2010

PhRMA  |  Press Release

Washington, D.C. (April 12, 2010) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President for Scientific & Regulatory Affairs Dr. David E. Wheadon testified today at the Food and Drug Administration’s (FDA) public...
https://www.phrma.org/press-release/phrma-statement-on-pdufa-reauthorization-2010

PhRMA Statement on President’s 2011 Budget Proposal

PhRMA  |  Press Release

Washington, D.C. (February 2, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today on the White House’s fiscal year 2011 budget: “We look forward to thoroughly reviewing the President’s bud...
https://www.phrma.org/press-release/phrma-statement-on-president-s-2011-budget-proposal

PhRMA Statement About Accessing Online Health Information

PhRMA  |  Press Release

Washington, D.C. (March 9, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President David E. Wheadon issued the following statement regarding patients’ access to reliable health information online: “PhRMA .org/about/me...
https://www.phrma.org/press-release/phrma-statement-about-accessing-online-health-information

PhRMA Encouraged by Decline in Cancer Death Rate

PhRMA  |  Press Release

Washington, D.C. (May 27, 2009) –– Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement regarding the American Cancer Society’s (ACS) .can...
https://www.phrma.org/press-release/phrma-encouraged-by-decline-in-cancer-death-rate

PhRMA on the State of the Union Address

PhRMA  |  Press Release

Washington, D.C. (January 29, 2014) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement: "President Obama’s address comes at a time when America’s biopharmaceutical research companies are bringi...
https://www.phrma.org/press-release/phrma-on-the-state-of-the-union-address1

PhRMA Statement On Markup Of H.R. 9, The Innovation Act

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-statement-on-markup-of-h-r-9-the-innovation-act

Research Supported by Biopharmaceutical Companies Boosts Economy, Benefits Local Patients

PhRMA  |  Press Release

The report, "Research in Your Backyard: Pharmaceutical Clinical Trials in Nebraska," was released today at a conference at the University of Nebraska Medical Center (UNMC), which has conducted extensive clinical research in collaboration with biopharmaceutical research companies. 
https://www.phrma.org/press-release/research-supported-by-biopharmaceutical-companies-boosts-economy-benefits-local-patients

Scientific Progress Spurs Research Into Record Number of Cancer Medicines

PhRMA  |  Press Release

When PhRMA released its first accounting of medicines in development for cancer in 1988, only 65 were recorded.
https://www.phrma.org/press-release/scientific-progress-spurs-research-into-record-number-of-cancer-medicines

You have reviewed the first 250 results out of 877. Each page contains 25 results. You're on page 10.

prev 7 8 9 10 11 12 next